Pharmacokinetic Study of ASP1517 - Evaluation of the Effect of Lanthanum Carbonate Hydrate on the Pharmacokinetics of ASP1517 in Non-elderly Healthy Adult Male Subjects.
Phase of Trial: Phase I
Latest Information Update: 02 Feb 2017
At a glance
- Drugs Lanthanum carbonate (Primary) ; Roxadustat (Primary)
- Indications Anaemia; Hyperphosphataemia
- Focus Pharmacokinetics
- Sponsors Astellas Pharma
- 23 Jan 2017 Status changed from recruiting to completed.
- 08 Dec 2016 Status changed from not yet recruiting to recruiting.
- 08 Nov 2016 New trial record